These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 27797462)
1. Paving the way to a bioresorbable technology: Development of the absorb BRS program. Perkins LE; Kossuth MB; Fox JC; Rapoza RJ Catheter Cardiovasc Interv; 2016 Nov; 88(S1):1-9. PubMed ID: 27797462 [TBL] [Abstract][Full Text] [Related]
3. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials. Rizik DG; Hermiller JB; Kereiakes DJ Catheter Cardiovasc Interv; 2016 Nov; 88(S1):21-30. PubMed ID: 27797464 [TBL] [Abstract][Full Text] [Related]
4. The unmet needs: How future technologies will address current limitations of bioresorbable scaffold technology. Abizaid A; Ribamar Costa J Catheter Cardiovasc Interv; 2016 Nov; 88(S1):54-59. PubMed ID: 27797459 [TBL] [Abstract][Full Text] [Related]
5. Bioresorbable vascular scaffolds in left main coronary artery disease. Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148 [TBL] [Abstract][Full Text] [Related]
6. In vitro mechanical behavior and in vivo healing response of a novel thin-strut ultrahigh molecular weight poly-l-lactic acid sirolimus-eluting bioresorbable coronary scaffold in normal swine. Cheng Y; Gasior P; Ramzipoor K; Lee C; McGregor JC; Conditt GB; McAndrew T; Kaluza GL; Granada JF Int J Cardiol; 2019 Jul; 286():21-28. PubMed ID: 30967275 [TBL] [Abstract][Full Text] [Related]
7. Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry. La Manna A; Chisari A; Giacchi G; Capodanno D; Longo G; Di Silvestro M; Capranzano P; Tamburino C Catheter Cardiovasc Interv; 2016 Nov; 88(6):E155-E163. PubMed ID: 26756959 [TBL] [Abstract][Full Text] [Related]
8. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study. Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119 [TBL] [Abstract][Full Text] [Related]
10. Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure. Tanaka A; Jabbour RJ; Latib A; Colombo A Catheter Cardiovasc Interv; 2016 Nov; 88(S1):10-20. PubMed ID: 27797460 [TBL] [Abstract][Full Text] [Related]
11. Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry. Ortega-Paz L; Capodanno D; Giacchi G; Gori T; Nef H; Latib A; Caramanno G; Di Mario C; Naber C; Lesiak M; Capranzano P; Wiebe J; Mehilli J; Araszkiewicz A; Pyxaras S; Mattesini A; Geraci S; Naganuma T; Colombo A; Münzel T; Sabaté M; Tamburino C; Brugaletta S Catheter Cardiovasc Interv; 2017 Apr; 89(5):812-818. PubMed ID: 27515568 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous coronary intervention: balloons, stents and scaffolds. Colleran R; Kastrati A Clin Res Cardiol; 2018 Aug; 107(Suppl 2):55-63. PubMed ID: 30039189 [TBL] [Abstract][Full Text] [Related]
13. Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease. Dziewierz A; Dudek D Kardiol Pol; 2018; 76(7):1043-1054. PubMed ID: 30251247 [TBL] [Abstract][Full Text] [Related]
14. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial. Bennett J; Adriaenssens T; Desmet W; Dubois C Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586 [TBL] [Abstract][Full Text] [Related]
15. Latest generation stents: is it time to revive the bioresorbable scaffold? Buono A; Ielasi A; Colombo A Minerva Cardioangiol; 2020 Oct; 68(5):415-435. PubMed ID: 32643897 [TBL] [Abstract][Full Text] [Related]
16. Role of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology. Chamié D; Garcia-Garcia H; Costa RA; Onuma Y; Abizaid A; Serruys PW Catheter Cardiovasc Interv; 2016 Nov; 88(S1):38-53. PubMed ID: 27797463 [TBL] [Abstract][Full Text] [Related]